Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 5, 2025Frontiers in Cardiovascular MedicineOpen Access

Ultrasound-targeted microbubble destruction: a prospective strategy for treating cardiovascular disease

View Full Paper
Ask AI
Bookmark
Share

Authors

SYShuting YangJiangsu UniversityRZRong ZhangInner Mongolia Normal UniversityHZHuali ZhangKunming University of Science and Technology

Discussion

Loading...

Member takes

Overview

Review highlights ultrasound-targeted microbubble destruction and its potential in treating cardiovascular disease.

Key Points

  • Ultrasound-targeted microbubble destruction significantly enhances drug delivery to target tissues, providing new avenues for treatment.
  • The technique leverages cavitation and sonoporation, improving the efficacy of gene and drug therapies for cardiovascular disease.
  • A decade of studies demonstrates the promise of this approach, addressing the increasing healthcare burden of cardiovascular disease.
  • Future prospects include overcoming existing limitations and exploring various substances that can be delivered via microbubbles.

Cite This Study

Yang et al. (2025) studied this question.

synapsesocial.com/papers/68bb49d26d6d5674bccfffd0https://doi.org/10.3389/fcvm.2025.1634059
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Targeting TRAF3IP2 by Genetic and Interventional Approaches Inhibits Ischemia/Reperfusion-induced Myocardial Injury and Adverse Remodeling2017 · 36 citations
  2. 2Research progress of therapeutic drugs for doxorubicin-induced cardiomyopathy2022 · 120 citations
  3. 3Ultrasound‑targeted microbubble destruction technology delivering β‑klotho to the heart enhances FGF21 sensitivity and attenuates heart remodeling post‑myocardial infarction2024 · 19 citations
  4. 4Burden of Ischaemic heart disease and attributable risk factors in China from 1990 to 2015: findings from the global burden of disease 2015 study2018 · 116 citations
  5. 5TGF-β1 and TIMP1 double directional rAAV targeted by UTMD in atherosclerotic vulnerable plaque2017 · 5 citations